Parathyroid hormone and growth in chronic kidney disease

Pediatric Nephrology

Volumn 26, Issue 2, 2011, Pages 195-204

  Waller, Simon ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Chronic kidney disease; Chronic kidney disease metabolic bone disorder; Growth; Parathyroid hormone

Indexed keywords

CALCIMIMETIC AGENT; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; VITAMIN D;

BONE TURNOVER; CALCIUM HOMEOSTASIS; CHILD; CHRONIC KIDNEY DISEASE; DIET RESTRICTION; GLOMERULUS FILTRATION RATE; GROWTH DISORDER; GROWTH PLATE; HUMAN; INFANT; METABOLIC BONE DISEASE; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

BONE DISEASES, METABOLIC; CHILD; CHILD DEVELOPMENT; GROWTH; HUMANS; PARATHYROID HORMONE; RENAL INSUFFICIENCY, CHRONIC;

EID: 78751571224     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1614-y     Document Type: Review

References (68)

1. RN Fine 1992 Stimulating growth in uremic children Kidney Int 42 188 197 1:STN:280:DyaK38zktFKqug%3D%3D 10.1038/ki.1992.277 1635349
2. Haffner D, Nissel R (2008) Growth and puberty in chronic kidney disease. In: Geary DF, Schaefer F (eds) Comprehensive pediatric nephrology. Elsevier, Philadelphia, pp S709-S732
3. SL Furth W Hwang C Yang AM Neu BA Fivush NR Powe 2002 Growth failure, risk of hospitalization and death for children with end-stage renal disease Pediatr Nephrol 17 450 455 10.1007/s00467-002-0838-x 12107811
4. CS Wong DS Gipson DL Gillen S Emerson T Koepsell DJ Sherrard SL Watkins C Stehman-Breen 2000 Anthropometric measures and risk of death in children with end-stage renal disease Am J Kidney Dis 36 811 819 1:STN:280: DC%2BD3cvpsVeitg%3D%3D 10.1053/ajkd.2000.17674 11007685
5. EM Brown 1999 Physiology and pathophysiology of the extracellular calcium-sensing receptor Am J Med 106 238 253 1:CAS:528:DyaK1MXitVSns74%3D 10.1016/S0002-9343(98)00418-5 10230755
6. D Haffner DC Fischer 2009 Growth hormone treatment of infants with chronic kidney disease: requirement, efficacy, and safety Pediatr Nephrol 24 1097 1100 10.1007/s00467-009-1192-z 19373491
7. H Strid M Simren PO Stotzer H Abrahamsson ES Bjornsson 2004 Delay in gastric emptying in patients with chronic renal failure Scand J Gastroenterol 39 516 520 1:STN:280:DC%2BD2czmvFCisA%3D%3D 10.1080/00365520410004505 15223673
8. JA Kari C Gonzalez SE Ledermann V Shaw L Rees 2000 Outcome and growth of infants with severe chronic renal failure Kidney Int 57 1681 1687 1:STN:280:DC%2BD3c3itlKjsA%3D%3D 10.1046/j.1523-1755.2000.00013.x 10760104
9. SE Ledermann V Shaw RS Trompeter 1999 Long-term enteral nutrition in infants and young children with chronic renal failure Pediatr Nephrol 13 870 875 1:STN:280:DC%2BD3c%2FmvV2qtQ%3D%3D 10.1007/s004670050718 10603139
10. M Van Dyck S Sidler W Proesmans 1998 Chronic renal failure in infants: effect of strict conservative treatment on growth Eur J Pediatr 157 759 762 1:STN:280:DyaK1cvkslCgsA%3D%3D 10.1007/s004310050930 9776537
11. F Schaefer AM Wingen M Hennicke S Rigden O Mehls 1996 Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood Pediatr Nephrol 10 288 293 1:STN:280:DyaK28zosVGjtg%3D%3D 8792392
12. CL Abitbol G Zilleruelo B Montane J Strauss 1993 Growth of uremic infants on forced feeding regimens Pediatr Nephrol 7 173 177 1:STN:280: DyaK3s3jslShug%3D%3D 10.1007/BF00864388 8476713
13. R Shroff E Wright S Ledermann C Hutchinson L Rees 2003 Chronic hemodialysis in infants and children under 2 years of age Pediatr Nephrol 18 378 383 12700966
14. A Hokken-Koelega P Mulder R De Jong M Lilien R Donckerwolcke J Groothof 2000 Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency Pediatr Nephrol 14 701 706 1:STN:280:DC%2BD3M%2Fjt1yksw%3D%3D 10.1007/s004670000340 10912546
15. S Picca M Cappa C Martinez SI Moges J Osborn F Perfumo G Ardissino R Bonaudo G Montini G Rizzoni 2004 Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone Pediatr Nephrol 19 71 76 10.1007/s00467-003-1283-1 14634859
16. FA Tylavsky KA Ryder A Lyytikainen S Cheng 2005 Vitamin D, parathyroid hormone, and bone mass in adolescents J Nutr 135 2735S 2738S 1:CAS:528:DC%2BD2MXht1CgsbjI 16251640
17. FN Ali LM Arguelles CB Langman HE Price 2009 Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic Pediatrics 123 791 796 10.1542/peds.2008-0634 19255004
18. V Belostotsky MZ Mughal JL Berry NJ Webb 2008 Vitamin D deficiency in children with renal disease Arch Dis Child 93 959 962 1:STN:280: DC%2BD1cnnsFOrsg%3D%3D 10.1136/adc.2007.134866 18463127
19. EA Gonzalez A Sachdeva DA Oliver KJ Martin 2004 Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study Am J Nephrol 24 503 510 1:CAS:528:DC%2BD2cXhtVGmtrjF 10.1159/000081023 15452403
20. MF Holick 1987 Vitamin D and the kidney Kidney Int 32 912 929 1:STN:280:DyaL1c7hvF2ktA%3D%3D 10.1038/ki.1987.295 2828754
21. SA Abrams IJ Griffin KM Hawthorne SK Gunn CM Gundberg TO Carpenter 2005 Relationships among vitamin D levels, parathyroid hormone, and calcium absorption in young adolescents J Clin Endocrinol Metab 90 5576 5581 1:CAS:528:DC%2BD2MXhtFWjt7zK 10.1210/jc.2005-1021 16076940
22. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Available at http://www.kidney.org/professionals/kdoqi/guidelines- pedbone/guide8.htm
23. S Moe T Drueke J Cunningham W Goodman K Martin K Olgaard S Ott S Sprague N Lameire G Eknoyan 2006 Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 69 1945 1953 1:STN:280:DC%2BD283ptl2nug%3D%3D 10.1038/sj.ki.5000414 16641930
24. BD Kuizon IB Salusky 2002 Cell biology of renal osteodystrophy Pediatr Nephrol 17 777 789 10.1007/s00467-002-0919-x 12376803
25. R Coppo MG Porcellini R Bonaudo L Peruzzi A Amore G Conti 1998 Providing the right stuff: feeding children with chronic renal failure J Nephrol 11 171 176 1:STN:280:DyaK1czms1ChtQ%3D%3D 9702867
26. DJ Sherrard G Hercz Y Pei NA Maloney C Greenwood A Manuel C Saiphoo SS Fenton GV Segre 1993 The spectrum of bone disease in end-stage renal failure-an evolving disorder Kidney Int 43 436 442 1:STN:280:DyaK3s7otVersQ%3D%3D 10.1038/ki.1993.64 8441240
27. IB Salusky JA Ramirez W Oppenheim B Gales GV Segre WG Goodman 1994 Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD Kidney Int 45 253 258 1:STN:280:DyaK2c7nt12nsw%3D%3D 10.1038/ki.1994.31 8127016
28. E Slatopolsky A Brown A Dusso 1999 Pathogenesis of secondary hyperparathyroidism Kidney Int Suppl 73 S14 S19 1:CAS:528:DC%2BD3cXivFKitw%3D%3D 10.1046/j.1523-1755.1999.07304.x 10633458
29. Y Almaden A Hernandez V Torregrosa A Canalejo L Sabate CL Fernandez JM Campistol A Torres M Rodriguez 1998 High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro J Am Soc Nephrol 9 1845 1852 1:CAS:528:DyaK1cXmslCju7w%3D 9773785
30. J Silver R Kilav A Sela-Brown T Naveh-Many 2000 Molecular mechanisms of secondary hyperparathyroidism Pediatr Nephrol 14 626 628 1:STN:280: DC%2BD3M%2Fjt1ymtA%3D%3D 10.1007/s004670000355 10912531
31. ML Picton PR Moore EB Mawer D Houghton AJ Freemont AJ Hutchison R Gokal JA Hoyland 2000 Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure Kidney Int 58 1440 1449 1:CAS:528:DC%2BD3cXntlyltLs%3D 10.1046/j.1523-1755.2000.00306.x 11012879
32. Goodman W, Coburn J, Slatopolsky E, Salusky I (1999) Renal osteodystrophy in adults and children. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott Williams and Wilkins, Philadelphia, pp 347-363
33. CB French M Genel 1986 Pathophysiology of growth failure in chronic renal insufficiency Kidney Int Suppl 19 S59 S64 1:STN:280:DyaL28zgvV2gsw%3D%3D 3528627
34. B Krempien O Mehls E Ritz 1974 Morphological studies on pathogenesis of epiphyseal slipping in uremic children Virchows Arch A Pathol Anat Histol 362 129 143 1:STN:280:DyaE2c7kvFWltQ%3D%3D 10.1007/BF00432391 4824457
35. BD Kuizon WG Goodman H Juppner I Boechat P Nelson B Gales IB Salusky 1998 Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD Kidney Int 53 205 211 1:CAS:528:DyaK1cXnsFCiuw%3D%3D 10.1046/j.1523-1755.1998.00724.x 9453020
36. S Waller R Shroff AJ Freemont L Rees 2008 Bone histomorphometry in children prior to commencing renal replacement therapy Pediatr Nephrol 23 1523 1529 10.1007/s00467-008-0838-6 18481109
37. CP Schmitt G Ardissino S Testa A Claris-Appiani O Mehls 2003 Growth in children with chronic renal failure on intermittent versus daily calcitriol Pediatr Nephrol 18 440 444 12687466
38. MG Seikaly N Salhab D Gipson V Yiu D Stablein 2006 Stature in children with chronic kidney disease: analysis of NAPRTCS database Pediatr Nephrol 21 793 799 10.1007/s00467-006-0040-7 16583244
39. S Waller S Ledermann R Trompeter HW van't D Ridout L Rees 2003 Catch-up growth with normal parathyroid hormone levels in chronic renal failure Pediatr Nephrol 18 1236 1241 10.1007/s00467-003-1284-0 14586680
40. J Cansick S Waller D Ridout L Rees 2007 Growth and PTH in prepubertal children on long-term dialysis Pediatr Nephrol 22 1349 1354 10.1007/s00467-006- 0348-3 17111159
41. SC Waller D Ridout T Cantor L Rees 2005 Parathyroid hormone and growth in children with chronic renal failure Kidney Int 67 2338 2345 1:CAS:528:DC%2BD2MXlsFyjurw%3D 10.1111/j.1523-1755.2005.00339.x 15882277
42. A Claris-Appiani ML Bianchi P Bini G Ballabio MP Caraceni C Funari F Terzi L Romeo R Rusconi 1989 Growth in young children with chronic renal failure Pediatr Nephrol 3 301 304 1:STN:280:DyaK3M%2Fgt1Wgsw%3D%3D 10.1007/BF00858536 2702111
43. KA Hruska SL Teitelbaum 1995 Renal osteodystrophy N Engl J Med 333 166 174 1:STN:280:DyaK2Mzht1Sitg%3D%3D 10.1056/NEJM199507203330307 7791820
44. IB Salusky BD Kuizon TR Belin JA Ramirez B Gales GV Segre WG Goodman 1998 Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration Kidney Int 54 907 914 1:CAS:528:DyaK1cXlvVCmsLc%3D 10.1046/j.1523-1755.1998.00045.x 9734615
45. H Ziolkowska M Paniczyk-Tomaszewska A Debinski Z Polowiec A Sawicki M Sieniawska 2000 Bone biopsy results and serum bone turnover parameters in uremic children Acta Paediatr 89 666 671 1:STN:280:DC%2BD3M%2FotFentg%3D%3D 10.1080/080352500750043963 10914959
46. F Santos E Carbajo-Perez J Rodriguez M Fernandez-Fuente I Molinos B Amil E Garcia 2005 Alterations of the growth plate in chronic renal failure Pediatr Nephrol 20 330 334 10.1007/s00467-004-1652-4 15549411
47. CP Sanchez IB Salusky BD Kuizon P Abdella H Juppner WG Goodman 1998 Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol Kidney Int 54 1879 1887 1:CAS:528:DyaK1cXotVagsr0%3D 10.1046/j.1523-1755.1998.00199.x 9853253
48. A Cobo JM Lopez E Carbajo F Santos J Alvarez M Fernandez A Weruaga 1999 Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats J Am Soc Nephrol 10 971 979 1:STN:280: DyaK1M3kslKnsA%3D%3D 10232682
49. J Green R Goldberg G Maor 2003 PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis Kidney Int 63 487 500 1:CAS:528:DC%2BD3sXht1yrsLo%3D 10.1046/j.1523-1755.2003.00773.x 12631114
50. G Klaus T May U Hugel B von Eichel J Rodriguez P Fernandez J Reichrath E Ritz O Mehls 1997 Parathyroid hormone prevents 1,25 (OH)2D3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro Kidney Int 52 45 51 1:CAS:528:DyaK2sXks1equ74%3D 10.1038/ki.1997.302 9211345
51. CP Sanchez BD Kuizon PA Abdella H Juppner IB Salusky WG Goodman 2000 Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure Endocrinology 141 1536 1544 1:CAS:528:DC%2BD3cXisFOku7w%3D 10.1210/en.141.4.1536 10746661
52. WG Goodman IB Salusky H Juppner 2002 New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments Nephrol Dial Transplant 17 1731 1736 1:CAS:528: DC%2BD38Xot1CisL4%3D 10.1093/ndt/17.10.1731 12270977
53. R Lepage L Roy JH Brossard L Rousseau C Dorais C Lazure P D'Amour 1998 A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples Clin Chem 44 805 809 1:CAS:528:DyaK1cXisFSitr0%3D 9554492
54. E Slatopolsky J Finch P Clay D Martin G Sicard G Singer P Gao T Cantor A Dusso 2000 A novel mechanism for skeletal resistance in uremia Kidney Int 58 753 761 1:CAS:528:DC%2BD3cXlvFags7g%3D 10916099
55. MC Langub MC Monier-Faugere G Wang JP Williams NJ Koszewski HH Malluche 2003 Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure Endocrinology 144 1135 1138 1:CAS:528:DC%2BD3sXisVehu7c%3D 10.1210/en.2002-221026 12639892
56. P Divieti MR John H Juppner FR Bringhurst 2002 Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor Endocrinology 143 171 176 1:CAS:528:DC%2BD38XjtVOqsA%3D%3D 10.1210/en.143.1.171 11751606
57. PP Divieti 2005 PTH and osteocytes J Musculoskelet Neuronal Interact 5 328 330 1:CAS:528:DC%2BD28XjtFyhsb4%3D 16340124
58. M Koshikawa K Nishiguchi S Yorifuji K Shimazu K Takaori K Mori E Eguchi K Okada A Tanaka T Kuwahara 2010 Amino terminal cleavage of PTH(1-84) to PTH(7-84) is regulated by serum calcium concentration via calcium-sensing receptor in hemodialysis patients Clin Exp Nephrol 14 233 238 1:CAS:528:DC%2BC3cXps1eksbc%3D 10.1007/s10157-010-0264-5 20127382
59. MC Monier-Faugere Z Geng H Mawad RM Friedler P Gao TL Cantor HH Malluche 2001 Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients Kidney Int 60 1460 1468 1:CAS:528: DC%2BD3MXnsFSju7o%3D 10.1046/j.1523-1755.2001.00949.x 11576360
60. G Coen E Bonucci P Ballanti A Balducci S Calabria GA Nicolai MS Fischer F Lifrieri M Manni M Morosetti E Moscaritolo D Sardella 2002 PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease Am J Kidney Dis 40 348 354 1:CAS:528:DC%2BD38XmsF2rsbk%3D 10.1053/ajkd.2002.34519 12148108
61. IB Salusky WG Goodman BD Kuizon JR Lavigne RJ Zahranik B Gales HJ Wang RM Elashoff H Juppner 2003 Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis Kidney Int 63 1801 1808 1:CAS:528:DC%2BD3sXjslygsb8%3D 10.1046/j.1523-1755.2003.00915.x 12675856
62. S Waller A Reynolds D Ridout T Cantor P Gao L Rees 2003 Parathyroid hormone and its fragments in children with chronic renal failure Pediatr Nephrol 18 1242 1248 10.1007/s00467-003-1267-1 14579141
63. K Wesseling-Perry GC Harkins HJ Wang R Elashoff B Gales MJ Horwitz AF Stewart H Juppner IB Salusky 2010 The Calcemic Response to Continuous Parathyroid Hormone (PTH)(1-34) Infusion in End-Stage Kidney Disease Varies According to Bone Turnover: A Potential Role for PTH(7-84) J Clin Endocrinol Metab 95 2772 2780 1:CAS:528:DC%2BC3cXnvVaksLg%3D 10.1210/jc.2009-1909 20382692
64. S Wu T Palese OP Mishra M Ivoria-Papadopoulos F De Luca 2004 Effects of Ca2+ sensing receptor activation in the growth plate FASEB J 18 143 145 1:CAS:528:DC%2BD2cXlvFOksQ%3D%3D 14597561
65. K Wesseling-Perry 2010 FGF-23 in bone biology Pediatr Nephrol 25 603 608 10.1007/s00467-009-1384-6 20012997
66. Available at http://www.kidney.org/professionals/kdoqi/guidelines- pedbone/guide1.htm#table3
67. G Klaus A Watson A Edefonti M Fischbach K Ronnholm F Schaefer E Simkova CJ Stefanidis V Strazdins J Vande Walle C Schroder A Zurowska M Ekim 2006 Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines Pediatr Nephrol 21 151 159 1:STN:280: DC%2BD28%2FivVWisw%3D%3D 10.1007/s00467-005-2082-7 16247644
68. L Rees 2008 What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 23 179 184 10.1007/s00467-007-0684-y 18043947